Dominick J Angiolillo Selected Research

bivalirudin (Angiomax)

11/2023	Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome.
7/2023	Bivalirudin in acute coronary syndromes.
11/2020	Radial versus femoral and bivalirudin versus unfractionated heparin in vulnerable patients with acute coronary syndromes.
12/2016	Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications.
9/2016	Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplasty.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominick J Angiolillo Research Topics

Disease

199	Hemorrhage 05/2024 - 08/2008
145	Acute Coronary Syndrome 05/2024 - 06/2003
109	Thrombosis (Thrombus) 04/2024 - 05/2004
107	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2005
96	Myocardial Infarction 04/2024 - 02/2002
55	Stroke (Strokes) 03/2024 - 01/2008
53	Diabetes Mellitus 11/2022 - 07/2006
40	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 06/2004
30	ST Elevation Myocardial Infarction 04/2024 - 07/2013
19	Atrial Fibrillation 01/2024 - 10/2011
18	Chronic Renal Insufficiency 04/2024 - 03/2010
18	Type 2 Diabetes Mellitus (MODY) 01/2021 - 08/2005
11	Ischemia 01/2023 - 09/2008
10	Death (Near-Death Experience) 11/2021 - 08/2004
9	Atherosclerosis 01/2023 - 12/2009
9	Unstable Angina 01/2022 - 02/2003
8	Inflammation (Inflammations) 01/2023 - 11/2006
8	Coronary Disease (Coronary Heart Disease) 01/2021 - 08/2005
7	Peripheral Arterial Disease 03/2024 - 09/2007
6	Body Weight (Weight, Body) 01/2023 - 11/2012
6	Ischemic Stroke 01/2022 - 04/2016
6	Hyperplasia 04/2008 - 08/2004
5	Infarction (Infarctions) 10/2023 - 07/2013
5	Vascular Diseases (Vascular Disease) 03/2022 - 02/2014
5	Neoplasms (Cancer) 01/2022 - 01/2018
4	Dyspnea (Shortness of Breath) 02/2024 - 06/2012
4	Overweight 10/2022 - 04/2004
4	Anemia 11/2021 - 09/2012
4	Coronary Stenosis (Coronary Artery Stenosis) 07/2015 - 10/2005
3	COVID-19 12/2023 - 01/2021
3	Aortic Valve Stenosis (Aortic Stenosis) 11/2022 - 10/2019
3	Pain (Aches) 01/2022 - 01/2018
3	Thrombocytopenia (Thrombopenia) 11/2021 - 01/2018
3	Myocardial Ischemia (Ischemic Heart Diseases) 12/2020 - 02/2003
3	AIDS-Related Complex (ARC) 01/2020 - 01/2019
3	Coronary Thrombosis 01/2018 - 01/2004
3	Hypertension (High Blood Pressure) 04/2016 - 09/2007
3	Transient Ischemic Attack 03/2015 - 01/2012
2	Hypersensitivity (Allergy) 01/2024 - 03/2008
2	Venous Thromboembolism 01/2024 - 01/2022
2	Thromboembolism 12/2023 - 01/2021
2	Obesity 10/2023 - 09/2022

Drug/Important Bio-Agent (IBA)

147	Clopidogrel (Plavix)FDA Link 04/2024 - 04/2004
136	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2024 - 05/2004
103	TicagrelorIBA 05/2024 - 08/2008
71	Prasugrel Hydrochloride FDA Link 05/2024 - 12/2007
60	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2024 - 12/2009
28	AnticoagulantsIBA 01/2024 - 12/2008
26	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 04/2007
20	omega-Chloroacetophenone (Mace)IBA 11/2023 - 02/2009
20	Adenosine Diphosphate (ADP)IBA 08/2022 - 01/2007
17	cangrelorIBA 01/2023 - 08/2008
16	Purinergic P2Y Receptor AntagonistsIBA 01/2022 - 07/2010
14	Thrombin FDA Link 01/2023 - 01/2010
9	TabletsIBA 04/2024 - 05/2016
8	MetalsIBA 01/2021 - 03/2005
8	vorapaxarIBA 01/2020 - 08/2010
7	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2024 - 06/2010
7	Vitamin K FDA Link 01/2024 - 12/2016
7	C-Reactive ProteinIBA 01/2023 - 02/2002
7	Glycoproteins (Glycoprotein)IBA 05/2014 - 07/2004
6	Cytochrome P-450 CYP2C19IBA 04/2024 - 11/2011
6	Everolimus FDA Link 01/2024 - 01/2020
6	thienopyridineIBA 04/2017 - 01/2007
6	Sirolimus (Rapamycin)FDA Link 04/2008 - 08/2005
5	bivalirudin (Angiomax)FDA Link 11/2023 - 09/2016
5	Tirofiban (Aggrastat)FDA Link 01/2021 - 08/2008
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2011
5	Insulin (Novolin)FDA Link 01/2014 - 07/2006
5	E 5555IBA 07/2012 - 05/2011
4	RivaroxabanIBA 11/2022 - 01/2018
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2019 - 01/2011
4	Streptokinase FDA Link 01/2018 - 12/2009
4	ThromboxanesIBA 08/2013 - 01/2010
4	Cilostazol (Pletal)FDA LinkGeneric 01/2013 - 09/2008
3	vasodilator-stimulated phosphoproteinIBA 04/2024 - 05/2018
3	Heparin (Liquaemin)FDA LinkGeneric 11/2023 - 11/2020
3	CobaltIBA 10/2023 - 01/2020
3	ChromiumIBA 10/2023 - 01/2020
3	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2021
3	insulin receptor-related receptor (IRR)IBA 01/2023 - 03/2022
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2012
3	CollagenIBA 08/2022 - 07/2004
3	Dabigatran FDA Link 01/2022 - 03/2016
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019 - 08/2015
3	CSL112IBA 01/2019 - 08/2015
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 12/2009
3	ThienopyridinesIBA 09/2014 - 01/2007
2	Proton Pump InhibitorsIBA 03/2024 - 06/2022
2	LipidsIBA 10/2023 - 12/2020

Therapy/Procedure

211	Therapeutics 04/2024 - 07/2006
167	Percutaneous Coronary Intervention 05/2024 - 01/2006
103	Stents 04/2024 - 05/2004
22	Drug-Eluting Stents 04/2024 - 03/2005
17	Secondary Prevention 04/2024 - 01/2010
9	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2023 - 02/2008
7	Drug Therapy (Chemotherapy) 04/2024 - 01/2012
4	Transcatheter Aortic Valve Replacement 05/2024 - 10/2019
3	Brachytherapy 08/2005 - 05/2004
2	Induced Hypothermia 09/2023 - 02/2014